secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2024-05-15T23:59:59+00:00
Accession:  0001079973-24-000738
Event type: earnings
Sentiment:  negative
Materiality: 0.72
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q1 net loss widens to $284K; revenue flat at $2.15M
-----------------------------------------------------------

- Net revenue $2.153M flat YoY ($2.165M); net loss $(284)K ($0.12/diluted) vs $(54)K loss ($0.02/sh).
- Gross margin declined to 38.8% from 43.2% due to inflation-driven cost increases.
- R&D spending rose 40% primarily for SpinDx drug testing platform development.
- Beta testing of SpinDx saliva THC detection expected later in 2024; commercial launch projected 2025.
- Smartphone pairing for LX9 breathalyzer expected in Q2 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997324000738/0001079973-24-000738-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997324000738/lclc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-24-000738

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer